Charles Schwab’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$149K Buy
2022
Q3
Sell
2022
Q2
$29K Sell
2022
Q1
$99K Sell
2021
Q4
$265K Buy
2021
Q3
$290K Sell
2021
Q2
$494K Buy
2021
Q1
$394K Buy
2020
Q4
$300K Hold
2020
Q3
$259K Buy
2020
Q2
$176K Buy
2020
Q1
$137K Hold
2019
Q4
$297K Buy
2019
Q3
$165K Sell
2019
Q2
$288K Buy